- ￥2500
- 爱必信(Absin)
- 中国
- abs174238
- 2025年07月10日
企业认证
相关产品推荐更多 >
Rabbit anti-C-Peptide Recombinant Monoclonal Antibody(638-36)
￥1570PerCP Rat anti-Mouse I-A/I-E Antibody（M5/114）
￥2400Rabbit anti-Phospho-MEK 4(Ser80) Polyclonal Antibody
￥2300Rabbit anti-PGRN Recombinant Monoclonal Antibody(S-1090-110)
￥600Rabbit anti-PSME4 Recombinant Monoclonal Antibody(S-1502-70)
￥600
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
99
- 供应商：
爱必信（上海）生物科技有限公司
- 规格：
50T
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
Expression and Isolation of Recombinant Antibody Fragments in E. coli
Central to the rapid growth in the study and application of recombinant antibodies in recent years is the ability to reliably and cost-effectively produce large quantities of functional protein. In contrast to glycosylated whole monoclonal
AntibodyDrug Conjugate (ADC) Clinical Pipeline: A Review
game, requiring thoughtful combination of antibody, linker, and drugs in the context of a target and a defined cancer indication. Lessons learned from the first-generation antibody–drug conjugate (ADC) and improvement of the technology guided the design
技术资料暂无技术资料 索取技术资料
